B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk

P Erhardt1, E J Schremser, G M Cooper

  • 1Department of Biology, Boston University, Boston, Massachusetts 02215, USA.

Insights

Overexpressing B-Raf kinase activates the MEK/Erk pathway, conferring resistance to apoptosis. This pathway protects cells by inhibiting caspase activation downstream of mitochondrial cytochrome c release.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Growth factor-dependent kinases, including PI 3-kinase and Raf kinases, are involved in preventing programmed cell death (apoptosis).
  • The MEK/Erk mitogen-activated protein kinase pathway plays a crucial role in cellular signaling and survival.

Purpose of the Study:

  • To investigate the role of B-Raf overexpression and the subsequent MEK/Erk pathway activation in apoptosis suppression.
  • To determine the specific mechanism by which B-Raf confers resistance to apoptosis.

Main Methods:

  • Established Rat-1 fibroblast cell lines overexpressing B-Raf.
  • Utilized MEK inhibitors (PD98059) and dominant-negative MEK mutants.
  • Assessed apoptosis induction by growth factor withdrawal and PI 3-kinase inhibition.
  • Measured cytochrome c release from mitochondria and subsequent caspase activation.

Main Results:

  • B-Raf overexpression led to constitutive Erk activation and resistance to apoptosis.
  • MEK activity was essential and sufficient for the antiapoptotic effects of B-Raf.
  • The B-Raf/MEK/Erk pathway conferred resistance at the level of cytosolic caspase activation, downstream of cytochrome c release.

Conclusions:

  • The B-Raf/MEK/Erk signaling pathway is a key regulator of apoptosis.
  • This pathway protects cells by inhibiting caspase activation, independent of mitochondrial integrity.
  • Targeting the B-Raf/MEK/Erk pathway may offer therapeutic strategies for preventing apoptosis in certain conditions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...